Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients
about
The Role of Gammaherpesviruses in Cancer PathogenesisCurrent concepts in primary effusion lymphoma and other effusion-based lymphomasKSHV: pathways to tumorigenesis and persistent infectionViral cyclins mediate separate phases of infection by integrating functions of distinct mammalian cyclinsIdentification of Viral and Host Proteins That Interact with Murine Gammaherpesvirus 68 Latency-Associated Nuclear Antigen during Lytic Replication: a Role for Hsc70 in Viral ReplicationA gammaherpesvirus Bcl-2 ortholog blocks B cell receptor-mediated apoptosis and promotes the survival of developing B cells in vivoNovel gammaherpesviruses in North American domestic cats, bobcats, and pumas: identification, prevalence, and risk factorsThoracic diseases associated with HIV infection in the era of antiretroviral therapy: clinical and imaging findings.Virus-encoded microRNAs facilitate gammaherpesvirus latency and pathogenesis in vivoInterferon regulatory factor 1 restricts gammaherpesvirus replication in primary immune cells.Pathology of lymphoma in HIV.How do viruses trick B cells into becoming lymphomas?The RBP-Jκ binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation.A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening.Exploitation of the complement system by oncogenic Kaposi's sarcoma-associated herpesvirus for cell survival and persistent infectionNF-κB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1Illumination of murine gammaherpesvirus-68 cycle reveals a sexual transmission route from females to males in laboratory mice.Interaction of gamma-herpesvirus genome maintenance proteins with cellular chromatin.Epstein-Barr virus-positive T/NK-cell lymphoproliferative disordersγ-Herpesvirus load as surrogate marker of early death in HIV-1 lymphoma patients submitted to high dose chemotherapy and autologous peripheral blood stem cell transplantation.Gammaherpesvirus small noncoding RNAs are bifunctional elements that regulate infection and contribute to virulence in vivoThe tumor virus landscape of AIDS-related lymphomasMurine Gammaherpesvirus 68 Pathogenesis Is Independent of Caspase-1 and Caspase-11 in Mice and Impairs Interleukin-1β Production upon Extrinsic Stimulation in Culture.Genome-wide siRNA screen for mediators of NF-κB activationATM facilitates mouse gammaherpesvirus reactivation from myeloid cells during chronic infection.EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latencySelective killing of Kaposi's sarcoma-associated herpesvirus lytically infected cells with a recombinant immunotoxin targeting the viral gpK8.1A envelope glycoprotein.Prevalence and risk factors of gammaherpesvirus infection in domestic cats in Central Europe.A Conserved Gammaherpesvirus Cyclin Specifically Bypasses Host p18(INK4c) To Promote Reactivation from Latency.Gammaherpesvirus Infection of Human Neuronal Cells.Ataxia telangiectasia mutated kinase controls chronic gammaherpesvirus infection.The peptide derived from the Ig-like domain of human herpesvirus 8 K1 protein induces death in hematological cancer cells.Human Mesenchymal Stem Cells of Diverse Origins Support Persistent Infection with Kaposi's Sarcoma-Associated Herpesvirus and Manifest Distinct Angiogenic, Invasive, and Transforming Phenotypes.Type I Interferon Counteracts Antiviral Effects of Statins in the Context of Gammaherpesvirus Infection.Murine Gammaherpesvirus 68 LANA and SOX Homologs Counteract ATM-Driven p53 Activity during Lytic Viral ReplicationHuman herpesvirus multiplex ddPCR detection in brain tissue from low- and high-grade astrocytoma cases and controls.Next-generation sequence analysis of the genome of RFHVMn, the macaque homolog of Kaposi's sarcoma (KS)-associated herpesvirus, from a KS-like tumor of a pig-tailed macaque.Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymeraseEfficient infection of a human B cell line with cell-free Kaposi's sarcoma-associated herpesvirus.Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer.
P2860
Q26767186-5F211768-4D5D-4D26-8DCF-D3233E34F399Q27005442-DFD82427-5C4B-4810-9698-8BE04ACD3E53Q27026000-3C2B064C-60C9-40B8-BEEA-081A02A2C03FQ28480476-8776FD86-064F-490A-B448-2D3CFA533892Q28505713-A0163F55-DB77-4AC6-9120-E55057032FE8Q28539635-C5557BEC-78A7-4434-9C47-7356AC6D5E95Q28659727-CE44807B-D0A4-4CD2-A1AB-ECF93E8A426EQ30364647-5528EC9C-5C91-4257-86B2-F79AE64F1113Q33709525-411D3297-DCEB-4E53-A9F1-59BA44615520Q33743822-DE76CD68-1343-4BAE-ABC3-DB78727628D3Q34020069-000BB769-C452-4070-A44B-F5939BDFD057Q34020096-68F2E98E-AC50-4CFF-973D-1002F833B94AQ34130213-FC9CC698-47CD-41E7-9183-1FC89D2D2624Q34179693-54C51D5D-B3FB-4E09-9E17-8D8947FAB23AQ34257818-D0B17E74-FE9B-4B2A-93C6-660199641289Q34352790-750C2DA4-64AB-4879-B013-1FCCB5E8899AQ34671906-4F65FD7B-3715-40F9-AC93-63E6DE009F80Q34717723-45E09746-4057-485B-996B-D2B69DA678A7Q35040638-B41AAD3B-2C55-4B69-89D7-A82D4D68354FQ35068371-0DB9B224-33A1-4DF6-927B-8D26F1CE35F8Q35111083-2BC921E5-3B7B-490F-AAF4-8D7EAC7283FCQ35607311-BD2F78CD-1CAE-43A0-85F7-17C6A98135CDQ35745447-09D8B0B1-69E3-412A-9DF6-8CD2CB002603Q35787254-F82B06AF-DEBA-4841-BCD2-40997FAFB43AQ35893600-582473B8-A441-4B49-98C8-3A3C22AA4E47Q35932258-4717AF4E-7BD4-4078-834E-A5ED4EE0E7FCQ35992503-8E1C02B1-2AAC-4162-822A-469977594E64Q36071106-075D3FFF-51A1-4E02-BD09-A4C702A8381EQ36208092-E0820BD0-E94B-486D-8BDA-2AB16B2769BAQ36346036-C0333E41-044A-4D78-9B9F-D2C8223596CDQ36397423-7814F4B5-241C-4A3A-86F2-5F362835F241Q36453798-F744B06E-AC34-4E14-967D-849A3337867BQ36548258-476A74BC-1EA1-49BB-AE75-E0DA80589CEDQ36694053-E177EB91-1B23-436A-91E6-B98CE7BCEFF3Q36736774-A0275985-C0CE-43EE-9759-0EA5C373E82BQ37125964-ED8A3399-FD6A-4819-AD5A-DEAA842EBE3DQ37336869-36B5C91C-B751-448E-88F9-E46965EA09A6Q37523020-01CE63E6-278F-4B0B-AFAF-44140A4BAF5FQ37547223-2B4E0F6D-B2F5-40CB-AAEB-7AAAFE6AA4D6Q37736423-B34AD468-D7B1-4342-8123-3E6587FB4C11
P2860
Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients
@en
Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients.
@nl
type
label
Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients
@en
Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients.
@nl
prefLabel
Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients
@en
Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients.
@nl
P2860
P1433
P1476
Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients
@en
P2093
Ethel Cesarman
P2860
P304
P356
10.1016/J.CANLET.2011.03.003
P407
P577
2011-04-13T00:00:00Z